Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Alpha‐lipoic acid for diabetic peripheral neuropathy

Esta versión no es la más reciente

ver la versión actual 11 enero 2024

Información

DOI:
https://doi.org/10.1002/14651858.CD012967Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 22 febrero 2018see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Neuromuscular

Copyright:
  1. Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Cristian Baicus

    Correspondencia a: Internal Medicine, Colentina University Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania

    [email protected]

  • Adrian Purcarea

    Internal Medicine, Charleville Regional Hospital, France AND Internist.ro Clinic, Romania, Brasov, Romania

  • Erik von Elm

    Cochrane Switzerland, Institute of Social and Preventive Medicine, Lausanne University Hospital, Lausanne, Switzerland

  • Caterina Delcea

    Internal Medicine, Colentina University Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania

  • Florentina L Furtunescu

    Public Health and Management, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania

Contributions of authors

FF and CB wrote a draft of the protocol; AP, CD, and EvE revised it. All authors approved the protocol. AP entered the protocol into RevMan 5 (RevMan 2014).

Sources of support

Internal sources

  • None, Other.

External sources

  • None, Other.

Declarations of interest

CB: none known

AP: none known

EvE: none known

CD: none known

FLF: none known

Acknowledgements

The Information Specialist of Cochrane Neuromuscular, Angela Gunn, developed the search strategy in consultation with the review authors.

The Methods section of this protocol is based on a template developed by Cochrane Neuromuscular from an original created by the Cochrane Airways Group.

This project was supported by the National Institute for Health Research (NIHR) via Cochrane Infrastructure funding to Cochrane Neuromuscular. The views and opinions expressed herein are those of the review authors and do not necessarily reflect those of the Systematic Reviews Programme, the NIHR, the NHS, or the Department of Health. Cochrane Neuromuscular is also supported by the MRC Centre for Neuromuscular Disease.

Version history

Published

Title

Stage

Authors

Version

2024 Jan 11

Alpha‐lipoic acid for diabetic peripheral neuropathy

Review

Cristian Baicus, Adrian Purcarea, Erik Elm, Caterina Delcea, Florentina L Furtunescu

https://doi.org/10.1002/14651858.CD012967.pub2

2018 Feb 22

Alpha‐lipoic acid for diabetic peripheral neuropathy

Protocol

Cristian Baicus, Adrian Purcarea, Erik von Elm, Caterina Delcea, Florentina L Furtunescu

https://doi.org/10.1002/14651858.CD012967

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.